| Name | tert-butyl N-[(1R)-1-[(3E)-3-[5-(trifluoromethyl)benzimidazol-2-ylidene]-1,2-oxazol-5-yl]ethyl]carbamate |
|---|---|
| Synonyms | (R)-tert-Butyl (1-(3-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)isoxazol-5-yl)ethyl)carbamate |
| Molecular Formula | C18H19F3N4O3 |
|---|---|
| Molecular Weight | 396.36400 |
| Exact Mass | 396.14100 |
| PSA | 95.47000 |
| LogP | 1.58760 |
| HS Code | 2934999090 |
|---|
|
~89%
1095824-21-7 |
| Literature: Sunesis Pharmaceuticals, Inc. Patent: US2009/36419 A1, 2009 ; Location in patent: Page/Page column 88 ; US 20090036419 A1 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |